2407 — Gaush Meditech Balance Sheet
0.000.00%
- HK$1.80bn
- HK$1.63bn
- CNY1.41bn
Annual balance sheet for Gaush Meditech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 533 | 308 | 609 | 814 | 833 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 195 | 173 | 172 | 169 | 149 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 947 | 749 | 1,090 | 1,326 | 1,391 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 28.7 | 31.9 | 85.5 | 127 | 126 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 1,029 | 2,236 | 2,427 | 2,718 | 2,844 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 407 | 1,281 | 441 | 493 | 892 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,110 | 2,210 | 3,083 | 1,249 | 1,163 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -81.3 | 25.6 | -656 | 1,470 | 1,680 |
Total Liabilities & Shareholders' Equity | 1,029 | 2,236 | 2,427 | 2,718 | 2,844 |
Total Common Shares Outstanding |